ESAF Bank announces fintech conclave

ESAF Small Finance Bank has announced its first fintech conclave providing fintech firms a platform to showcase their new digital banking solutions that facilitate last-mile financial inclusion.

The conclave endorses entrepreneurship in the banking sector and is open for start-ups, established and growth-phase technology firms, social innovators and entrepreneurs having innovative solutions that align with ESAF’s core mission of providing responsive banking services to underserved and unserved populations.

The competent finalist can eventually become a long-term strategic partner of the bank as the co-creator of new financial digital products that will be the latest enhancement in the banking sector, a press release said.

Fintech Conclave 2020 invites entrepreneurs who offer digital solutions to multi-partite banking. As the banking sector explores new digital avenues with customer satisfaction in the spotlight, the doors are open for entrepreneurs to devise digital products that meet the need.

K Paul Thomas, Managing Director and CEO,

Read More

Continue Reading

Hyde Engineering + Consulting Announces New VP of Global Engineering

BOULDER, Colorado, Sept. 21, 2020 /PRNewswire/ — Hyde Engineering + Consulting, Inc. (Hyde) announced that Sanjay Shah has accepted the position of Vice President of Global Engineering. Sanjay, based out of Hyde’s office in Ahmedabad, India, will provide subject matter expertise in conceptual and detailed design, process engineering, and commissioning and qualification services for Hyde’s growing global client base across the regions – Asia, Europe and Americas.

“Sanjay has been a great friend and colleague for many years. I am so happy and grateful that he is rejoining Hyde Engineering in a global role. I have the highest level of respect for Sanjay’s expertise as well as his abilities to inspire other team members in their pursuit of excellence. Welcome back Sanjay!”- John Hyde, Founder and CEO

Having founded Hyde Engineering in 1993, John Hyde continues as CEO, Chairman, and industry leader, driving Hyde’s U.S. and

Read More

Continue Reading

CFPB Announces new Consumer Advisory Board Members, No Respresentation for Debt Collectors Yet Again

Last week, the Consumer Financial Protection Bureau (CFPB) announced the newest members of its advisory boards, including the Consumer Advisory Board (CAB). Notably, the CAB is yet again devoid of representation from the debt collection industry, which has been a pattern ever since 2018, when the CFPB’s Former Acting Director Mick Mulvaney disbanded the advisory board on which Ohad Samet, CEO of TrueAccord, sat.

The newly announced CAB members include:

  • Chair of the CAB – Eric Kaplan, Director – Housing Finance Program, Milken Institute (Washington, DC)
  • Joaquin Altoro, CEO, Wisconsin Housing & Economic Development Authority (Madison, WI)
  • Nikitra Bailey, EVP, Center for Responsible Lending (Durham, NC)
  • Lorray Brown, Attorney/Consumer Law Attorney, Co-Director, Michigan Poverty Law Program (Ypsilanti, MI)
  • Nadine Cohen, Managing Attorney, Greater Boston Legal Services (Boston, MA)
  • David Ehrich, Executive Director, AIR – Alliance for Innovation Regulation (Washington, DC)
  • Mae Watson Grote, Founder and CEO, The Financial Clinic (Brooklyn,
Read More

Continue Reading

OTC Markets Group Announces Agenda for Financial Services Virtual Investor Conference on September 24th

NEW YORK, Sept. 21, 2020 /PRNewswire/ — Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming OTC Financial Services Conference.  Individual investors, institutional investors, advisors and analysts are invited to attend.

(PRNewsfoto/OTC Markets Group (Investor Con)

The conference will begin at 9:15 AM ET with a keynote presentation from Ed Mills, Managing Director – Washington Policy with Raymond James. The event will include presentations by senior representatives of banks and companies in the financial services industry as well as live question-and-answer sessions with investors.  Investors will be able to interact directly with company executives via interactive chat and download annual reports, investor kits, surveys and other information in a virtual “trade booth,” providing convenient access to company management in an online environment.  

“We are proud to highlight a diverse roster of financial services industry leaders and welcome esteemed keynote

Read More

Continue Reading

PINTEC Announces First Half 2020 Unaudited Financial Results | News

BEIJING, Sept. 21, 2020 (GLOBE NEWSWIRE) — Pintec Technology Holdings Limited (NASDAQ: PT) (“PINTEC” or the “Company”), a leading independent technology platform enabling financial services in China, today announced its unaudited financial results for the six months ended June 30, 2020.

First Half 2020 Financial Highlights

Total revenues decreased by 65.0% to RMB251.6million (US$35.6million) from RMB719.7 million in the same period of 2019. Gross profit was RMB42.7 million (US$6.0 million) compared to RMB296.9 million in the same period of 2019. Gross margin was 17.0% compared to 41.3% in the same period of 2019. Operating loss was RMB100.0 million (US$14.2 million) compared to operating income of RMB73.6 million in the same period of 2019. Net loss was RMB104.2 million (US$14.7 million) compared to net income of RMB81.2 million in the same period of 2019. Adjusted net loss1 was RMB96.9 million (US$13.7 million) compared to adjusted net income of RMB111.1 million in

Read More

Continue Reading

Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock

SAN DIEGO, Sept. 18, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease, announced today the pricing of its previously announced underwritten public offering of 16,129,032 shares of its common stock at a public offering price of $0.62 per share, resulting in gross proceeds of approximately $10,000,000, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the company. All shares of common stock to be sold in the public offering are being sold by Adamis.

The offering is expected to close on September 22, 2020, subject to the satisfaction of customary closing conditions. The company has also granted the underwriters a 30-day option to purchase up to 2,419,354 additional shares of its common stock to cover over-allotments, if any.

Raymond James & Associates, Inc.

Read More

Continue Reading

Enzon Pharmaceuticals Announces Key Dates for Rights Offering

CRANFORD, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) — Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) announced today the record date and expected subscription period for its previously-announced rights offering to raise proceeds of approximately $43 million. The proceeds from the rights offering will be utilized to position the Company as a public company acquisition vehicle, where it can become an acquisition platform and more fully utilize its net operating loss tax carryforwards and enhance stockholder value.

The Company filed Amendment Number 1 to its Registration Statement on Form S-1 providing 5:00 p.m., New York City time, on September 23, 2020 as the record date. Subject to the Registration Statement becoming effective on or about September 18, 2020, the Company intends to commence the rights offering on September 23, 2020.

Under the rights offering, holders of Enzon’s common stock will receive one transferable subscription right for each share of common

Read More

Continue Reading

The Cincinnati Insurance Company Chief Claims Officer Announces Retirement

CINCINNATI, Sept. 9, 2020 /PRNewswire/ — Cincinnati Financial Corporation (Nasdaq: CINF) announced that Martin J. Mullen, CPCU, chief claims officer for its lead subsidiary, The Cincinnati Insurance Company, will retire at year-end.

Mullen joined the company in 1977 as a field claims representative serving agents and policyholders in Southwest Ohio. After more than a decade in the field, he joined the company’s headquarters claims management team and advanced through its ranks. In 2008, Mullen took the reins for the now 357-member headquarters claims team and the 958-member field claims team, carefully nurturing the company’s hallmark of excellent claims service.

Marc J. Schambow, CPCU, AIM, ASLI, vice president, Field Claims, will assume executive responsibility for the headquarters and field claims teams upon Mullen’s retirement. Schambow is a seasoned professional with more than 30 years of Cincinnati claims experience. After serving agents and policyholders in Wisconsin, he

Read More

Continue Reading

Vivera Pharmaceuticals announces Medical Technologies Division and BIOZONE Device

NEWPORT BEACH, Calif., Sept. 16, 2020 /PRNewswire/ — Vivera Pharmaceuticals, Inc. is pleased to announce the launch of BIOZONE, an innovative device designed for sanitization in high occupancy settings. Vivera’s BIOZONE device incorporates state of the art facial recognition, integrated biometrics, and a hospital grade organic sanitization mist.

BIOZONE device in hospital corridor

BIOZONE is able to detect body temperature, assign custom profiles for users, and provides surface disinfection of clothing and personal belongings. BIOZONE utilizes FDA and EPA approved hypochlorous acid (HOCl) mist safe for humans of all ages. Long used in clinical settings for wound care, infection control, and disinfection, HOCl is an effective defense against a variety of pathogens.

“Public health requires a stepwise approach to comprehensive COVID-19 containment,” stated Dr. Stephen McColgan, Vivera Pharmaceuticals’ Chief Medical Officer. “Safety in public spaces requires more than wearing a mask. Reopening schools, offices, and venues means

Read More

Continue Reading

TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical Trial

Phase 1 Dosing of Voriconazole Inhalation Powder up to 80 mg/dose in healthy subjects for direct-to-lung delivery of voriconazole for Invasive Pulmonary Aspergillosis (IPA)

Phase 2 studies to commence, assessing the efficacy of the dry powder formulation for the treatment of IPA

Company is investigating potential treatment or prevention of COVID-19 Associated Pulmonary Aspergillosis (CAPA) and other pulmonary fungal infections

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced topline safety data from its Phase 1 clinical trial of Voriconazole Inhalation Powder, a next-generation, direct-to-lung, inhaled dry powder version of voriconazole. Voriconazole is generally considered to be the most effective antifungal drug for treating Invasive Pulmonary Aspergillosis (IPA).

The recently completed Phase 1 trial was a randomized, double-blind, placebo-controlled study with an inhalation route of administration to 64 healthy adult

Read More

Continue Reading

Load More